OPINION

CCO firings a sign of agencies' waning tolerance for misbehavior

CCO firings a sign of agencies' waning tolerance for misbehavior

Men in high advertising posts are still misbehaving, but agencies are taking the behavior more seriously now, and acting swiftly to address it.

2018 Agency 100 preview: a complete guide to a year of disruption

2018 Agency 100 preview: a complete guide to a year of disruption

This year's version of the Agency 100 aims to give you the most complete guide to disruptions in the environment in which agencies operate, ranging from fresh data privacy and security worries, to newer kinds of innovation and enterprise technology work.

What I learned from taking my toddler to Cannes

What I learned from taking my toddler to Cannes

It's funny how closely a week at the Cannes International Festival of Creativity with my toddler mirrored exactly what it's like being a mom in general. It was an amazing, exhilarating, difficult, wonderful, draining, stressful, life-changing experience.

Is it time for pharma ad agencies to reboot?

Is it time for pharma ad agencies to reboot?

As global advertisers cut their spending, should the agency world take a hard look in the mirror?

A tale of two headlines leads to breast cancer confusion

A tale of two headlines leads to breast cancer confusion

Healthcare journalists and communicators have an obligation to facilitate informed conversation, not simply put out information. Does the Times' take on a recent gene test live up to that standard?

Transparency may have taken a back seat on this diversity drive

Transparency may have taken a back seat on this diversity drive

MM&M/Publicis Health's first Diversity Survey reveals some notable shifts to making the healthcare industry more inclusive, yet many agencies didn't feel like opening up about their diversity numbers.

Rethinking disability targeting

Rethinking disability targeting

If we properly and intentionally use the power of targeted marketing on behalf of our disabled customers, we might drive real value for an audience we've ignored for too long.

Long live the king: reflections on Sorrell's reign

Sorrell was good copy. He got into bruising takeover fights, took on media owners in trading negotiations, sued rivals and former employees, and clashed repeatedly with WPP's shareholders over his pay.

How pharma and healthcare shifted strategies post-blockbuster drug success

How pharma and healthcare shifted strategies post-blockbuster drug success

Remedy Health Media's Mike Collins discusses ways pharma and healthcare companies have shifted their strategies in the years after the success of blockbuster drugs.

Drugs' value to patients eclipsed by price tags

Drugs' value to patients eclipsed by price tags

Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.